Remi Barbier

Chairman of the Board, President & CEO
Remi Barbier has served as PTI's President and Chief Executive Officer since he founded the Company in 1998. Prior to PTI, Mr. Barbier helped in the growth or founding of: Exelixis Inc., a functional genomics company; ArQule, a chemistry company; and EnzyMed (now owned by Albany Molecular Research), a chemistry company. Prior to PTI Mr. Barbier served as Chief Operating Officer of Exelixis. Prior to that, he was Vice President of Corporate Development and Clinical Project Manager of Xoma Corporation, a biotechnology company. Mr. Barbier received his undergraduate degree from Oberlin College and his graduate degree from the University of Chicago.
Chairman of the Board